Literature DB >> 627871

Arenavirus defective interfering particles mask the cell-killing potential of standard virus.

F J Dutko, C J Pfau.   

Abstract

Lymphocytic choriomeningitis virus (LCM) and Pichinde virus grew readily and produced cytopathology in MDCK and PK-15 cells. It is known that in these cell lines, the synthesis or function of defective interfering (DI) virus particles is restricted. Survival curves of single MDCK cells infected with low multiplicities of LCM showed one-particle-to-kill kinetics. At high multiplicities of infection, there was a maximum degree of cell-killing, or even a reduction in the amount of cell-killing, depending on how much DI virus was present in a particular standard virus stock. DI LCM virus could completely prevent standard virus from producing c.p.e. in MDCK monolayers with one-particle-to-protect kinetics. It could still prevent killing of the cells when added within a short time after infection with standard virus, but was able to interfere with synthesis of standard virus when added even later, On passage of LCM or Pichinde virus without dilution in MDCK cells, there was no homologous auto-interference. Furthermore, there was only slight interference with the synthesis of standard virus when these cells were pre-treated with DI virus.

Entities:  

Mesh:

Year:  1978        PMID: 627871     DOI: 10.1099/0022-1317-38-2-195

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  12 in total

1.  Lassa virus nucleoprotein mutants generated by reverse genetics induce a robust type I interferon response in human dendritic cells and macrophages.

Authors:  Xavier Carnec; Sylvain Baize; Stéphanie Reynard; Laure Diancourt; Valérie Caro; Noel Tordo; Michèle Bouloy
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

2.  Homologous interference of lymphocytic choriomeningitis virus involves a ribavirin-susceptible block in virus replication.

Authors:  A Géssner; H Lother
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

3.  Regulation of Pichinde virus replication in Vero and BHK-21 cells.

Authors:  P R Young; S R Lee; C R Howard
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

4.  Molecular analysis of viral RNAs in mice persistently infected with lymphocytic choriomeningitis virus.

Authors:  S J Francis; P J Southern
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

5.  Evaluation of plaque size reduction as a method for the detection of Pichinde virus antibody.

Authors:  A C Chanas; P R Young; D S Ellis; G Mann; S Stamford; C R Howard
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

6.  Characterization of a nonvirulent variant of lymphocytic choriomeningitis virus.

Authors:  P R Brayton; H F Maassab
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

7.  Differences in Glycoprotein Complex Receptor Binding Site Accessibility Prompt Poor Cross-Reactivity of Neutralizing Antibodies between Closely Related Arenaviruses.

Authors:  Rachel B Brouillette; Elisabeth K Phillips; Natarajan Ayithan; Wendy Maury
Journal:  J Virol       Date:  2017-03-13       Impact factor: 5.103

8.  Cytotoxic T cells are induced in mice infected with lymphocytic choriomeningitis virus strains of markedly different pathogenicities.

Authors:  C J Pfau; J K Valenti; S Jacobson; D C Pevear
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

9.  Visualization of Arenavirus RNA Species in Individual Cells by Single-Molecule Fluorescence In Situ Hybridization Suggests a Model of Cyclical Infection and Clearance during Persistence.

Authors:  Benjamin R King; Aubin Samacoits; Philip L Eisenhauer; Christopher M Ziegler; Emily A Bruce; Daniel Zenklusen; Christophe Zimmer; Florian Mueller; Jason Botten
Journal:  J Virol       Date:  2018-05-29       Impact factor: 5.103

Review 10.  Defective Interfering Particles of Negative-Strand RNA Viruses.

Authors:  Christopher M Ziegler; Jason W Botten
Journal:  Trends Microbiol       Date:  2020-03-26       Impact factor: 17.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.